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104 Clinical proﬁle of Pseudomonas aeruginosa clone C infection in
CF children
S. Gopalakaje1, C.J. O’Brien1, A. Robb2, D.A. Spencer1. 1Great North Children’s
Hospital, Paediatric Respiratory Medicine, Newcastle, United Kingdom; 2Great
North Children’s Hospital, Department of Microbiology, Newcastle, United
Kingdom
Objectives: Several highly transmissible and virulent genotypes of Pseudomonas
aeruginosa have been recognised in the UK including the Liverpool, Midlands and
Manchester genotypes and Clone C. It has been suggested that patients colonised
with a transmissible genotype may have a poorer prognosis and increased treatment
needs. We describe the clinical features of patients who isolated P. aeruginosa
clone C in our paediatric CF centre.
Methods: The hospital microbiology database was used to identify the patients.
There were ﬁve isolations from ﬁve patients (four boys, aged 1−12 years, mean
4.4 years). All isolations were new, obtained from cough swabs performed at
routine clinics. Four patients had new wet cough, one of whom had reduced
lung function. One patient had no new clinical features. Four patients received
intravenous antibiotics and one patient oral antibiotics. The organisms were sensitive
to standard antipseudomonal antibiotics. The patients were removed from clinic and
seen separately until conﬁrmed negative for infection. Four patients remained free of
infection in the one year following isolation. Three patients underwent bronchoscopy
and BAL was culture negative. One patient had subsequent second isolation in
the same year. The frequency of pre and post pseudomonas isolation respiratory
exacerbations remains similar. All ﬁve are on conventional physiotherapy with no
additional requirement of pharmacological treatment of chest disease.
Conclusion: P. aeruginosa clone C isolates in our centre are currently sensitive to
standard antibiotics. We have found no evidence of increased virulence or that the
organism is overtly transmissible.
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Objectives: Pseudomonas aeruginosa (PA) can adapt to the host environment,
adopting a bioﬁlm-like lifestyle associated with increased antibiotic resistance,
leading to infections difﬁcult to treat with poor prognosis. We aim to investigate
the clinical impact of laboratory found adaptations of PA strains in 3 patients.
Methods: Sputum collection was performed in 2 consecutive years to study the
PA bioﬁlm. We reviewed the medical ﬁles of 3 patients in whom the lab found
evidence of transmission of PA (2002→2012).
Results: The patients, born in 1973 (A), 1982 (B) and 1975 (C), were colonized
with PA before 2000. Standard treatment was similar. Subject A suffered from
CFRD since 1990. A and C remained rather stable, with only mildly declining lung
functions (FEV1 declining from 83 resp. 57% in 2002 to 72 resp. 43%). B had a
greater decline in lung function (58% in 2002 to 26% in 2011), needed more IV
treatment, and was eventually transplanted in 2011. The same mucA gene mutation
was found in the PA isolates of the 3 patients, however the PA isolate of B also
showed a deletion in the lasR gene, which was not present in the PA isolates of A
and C.
Conclusion: We conclude that transmission occurred and that PA responds to a
rapidly evolving lung environment (a decline in pulmonary status) by accumulating
mutations in regulatory genes, such as the lasR gene.
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Cell-to-cell communication via gap junction (GJ) channels coordinates a signaling
network to regulate airway epithelial cell homeostasis and to maintain efﬁcient
epithelial host defense. In P. aeruginosa (Pa), cell-to-cell communication based on
quorum-sensing (QS) molecules is known to coordinate the production of virulence
factors and bioﬁlms by bacteria. QS signals may also incidentally modulate
mammalian cell response to the pathogen. We investigated here whether Pa N-3-
oxo-dodecanoyl-L-homoserine lactone (C12) may interfere with the host GJ cell-
to-cell communication in human airway epithelial cells (HAECs).
We demonstrate that C12, applied extra- or intracellularly, rapidly decreased GJ
conductivity in a reversible manner. Other QS molecules, including PQS, C4 or the
C12 analog dDHL, had no effect on GJ communication. We also show that C12
promoted calcium inﬂux in HAECs by activating store-operated calcium channels,
leading to loss of GJ function. In non-polarized HAECs, C12 evoked shrinkage
and blebbing that could be prevented by inhibitors of Src and ROCK signaling
pathways. The latter inhibitors also prevented GJ uncoupling in the presence of
C12. Interestingly, the effects of C12 on epithelium integrity were not observed on
polarized HAECs grown on Transwell ﬁlters. We further show that C12 degradation,
a reaction catalyzed by intracellular paraoxonase 2 (PON2), was more potent in
polarized cells. Interestingly, PON2 expression was decreased in non-polarized cells.
These results suggest that loss of HAEC integrity impairs C12 degradation, and thus
defense of the epithelium to the QS molecule, providing an additional mechanism
for Pa invasion.
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Objectives: Chronic bronchial infection (c.b.i.) with Burkholderia cepacia complex
(Bcc) in CF is a serious complication. Prevalence In the ECFS Registry 2008–2009
report was 0 to 11% (Spain 3.5%). Differences may be largely due to variable
Microbiology testing. Biochemical testing is not reliable and DNA testing is needed.
Bcc comprises 17 species. Most patients have infection with B. cenocepacia or
B. multivorans (Bm). Information on the outcome in patients infected with other
species is scarce.
Methods and Results: Bcc was grown in 28 CF patients since 1982 to December
2012. Strains were studied at a National Reference Laboratory except in two who
died with cepacia syndrome in 1991 and 2002. Eight had Bm, 7 B. contami-
nans (Bc), 4 B. cepacia (Bcp), 3 B. vietnamiensis (Bv), 3 B. stabilis (Bs) and
1 B. arboris. Their prevalence rose from 2/104 (2%) in 1997 to 22/174 (13%)
in 2011 and 17/180 (9.4%) in 2012. Twenty were colonized in 2009–2012. Age
at colonization was 19 years (6−36) and mean FEV1 73% Pred (106−34). Mean
follow-up is 3.4 years (0.2−14). The outcome was higly variable. Some had steep
decline (sd) and others little change. Follow-up was  2 years in 15. The mean
annual % FEV1 change (mac) ranged from −13 to + 15. Five (33%) had sd.
(mac−3): 4/7 with Bm and 1/2 with Bcp, vs none with Bs, Bv, or Bc. All
with either Bm or Bcp developed c.b.i. vs 0/3 with Bs, 1/2 with Bv and 1/1 with
Bc.
Conclusion: Our increasing prevalence of Bcc probably mirrors changing labora-
tory methods with all suspicious strains routinely studied at a Reference Laboratory
since 2009. The frequency of sd was higher in patients with Bm or Bcp but numbers
are very small. None with Bs has developed c.b.i.
